WeedMD Posts Q1 2021 Revenues Of $10.3 Million, Net Loss Of $7.0 Million
WeedMD (TSXV: WMD) this morning reported its first quarter 2021 financial results, posting revenues of $10.3 million, along with a net loss of $7.0 million for the period, an improvement on a quarter over quarter basis.
Revenues for the period amount to $10.3 million, an improvement from the $5.1 million in revenue recorded during the fourth quarter of 2020. However, with cost of goods sold of $10.0 million, the company reported a gross profit of just $0.3 million for the period before fair value adjustments.
Expenses didn’t help the matter here for the company, with selling, general and administrative expenses amounting to $6.0 million, while financing costs came in at $2.5 million. The company posted an operating loss of $10.3 million as a result.
This operating loss was then offset slightly by other income of $3.2 million, resulting in a loss of $7.0 million for the three month period. Adjusted EBITDA meanwhile was negative at $0.4 million.
In terms of the balance sheet, the company saw its cash position decrease slightly on a quarterly basis to that of $20.5 million, which includes the completion of a recent $17.3 million financing, while total current assets improved overall to $73.4 million. With accounts payable and accrued liabilities of $12.2 million, WeedMD posted total current liabilities of $21.2 million, resulting in positive working capital of $52.2 million.
WeedMD last traded at $0.28 on the TSX Venture.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
